INTERCEPT PHARMACEUTICALS, INC. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 632 | 13,588 | 9,536 | |
| Feb 26 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 222.50 | 632 | 140,620 | 2,166 | 2.8 K to 2.2 K (-22.59 %) |
| Feb 26 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 632 | 13,588 | 2,798 | 2.2 K to 2.8 K (+29.18 %) |
| Feb 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Option Exercise | M | 9.82 | 974 | 9,567 | 4,976 | |
| Feb 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Sell | S | 216.00 | 974 | 210,384 | 962 | 1.9 K to 962 (-50.31 %) |
| Feb 24 2015 | ICPT | INTERCEPT PHARMACE ... | WILLIAMS NICOLE | Director | Buy | M | 9.82 | 974 | 9,567 | 1,936 | 962 to 1.9 K (+101.25 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 5,294 | 45,882 | 35,425 | |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,500 | 36,400 | 3,703 | |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 212.12 | 2,000 | 424,242 | 18,796 | 20.8 K to 18.8 K (-9.62 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 210.95 | 1,146 | 241,749 | 20,796 | 21.9 K to 20.8 K (-5.22 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.62 | 1,500 | 306,930 | 21,942 | 23.4 K to 21.9 K (-6.40 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,500 | 36,400 | 23,442 | 19.9 K to 23.4 K (+17.55 %) |
| Feb 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 5,294 | 45,882 | 19,942 | 14.6 K to 19.9 K (+36.14 %) |
| Feb 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 233 | 5,010 | 10,168 | |
| Feb 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 195.52 | 233 | 45,556 | 2,166 | 2.4 K to 2.2 K (-9.71 %) |
| Feb 12 2015 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 233 | 5,010 | 2,399 | 2.2 K to 2.4 K (+10.76 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Option Exercise | M | 37.69 | 9,847 | 371,133 | 92,028 | |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 208.08 | 200 | 41,616 | 1,264 | 1.5 K to 1.3 K (-13.66 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 205.87 | 800 | 164,698 | 1,464 | 2.3 K to 1.5 K (-35.34 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 202.49 | 793 | 160,577 | 2,264 | 3.1 K to 2.3 K (-25.94 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 201.50 | 1,207 | 243,213 | 3,057 | 4.3 K to 3.1 K (-28.31 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Sell | S | 200.07 | 6,847 | 1,369,859 | 4,264 | 11.1 K to 4.3 K (-61.62 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Regan Daniel Paul | Chief Commercial Of ... | Buy | M | 37.69 | 9,847 | 371,133 | 11,111 | 1.3 K to 11.1 K (+779.03 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,500 | 36,400 | 7,203 | |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 4,000 | 34,667 | 10,971 | |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 208.10 | 953 | 198,317 | 14,648 | 15.6 K to 14.6 K (-6.11 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 207.01 | 2,379 | 492,466 | 15,601 | 18 K to 15.6 K (-13.23 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 206.03 | 1,068 | 220,041 | 17,980 | 19 K to 18 K (-5.61 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.20 | 3,100 | 633,009 | 19,048 | 22.1 K to 19 K (-14.00 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,500 | 36,400 | 22,148 | 18.6 K to 22.1 K (+18.77 %) |
| Feb 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 4,000 | 34,667 | 18,648 | 14.6 K to 18.6 K (+27.31 %) |